Forecasted mortality rates for pancreas malignant neoplasms in Japan indicate an upward trend from 20.41 thousand male deaths in 2024 to 22.01 thousand by 2028, highlighting a concerning rise. Year-on-year growth fluctuates slightly, with a consistent upward trajectory. In 2023, the mortality rate was recorded at 20.00 thousand male deaths, setting the base for this forecast. This implies continuous growth in the incidence or lethality of the disease.

Future trends to monitor include:

Advancements in medical technologies and their potential to slow mortality rates.
Public health initiatives aimed at early detection and prevention strategies.
Possible lifestyle changes and their impact on disease prevalence.